MDM2 inhibitor Idasanutlin potentiate therapeutic agents in Diffuse Large B-Cell Lymphoma by targeting MDM2 and XIAP

被引：0
|
作者：
Gu, Juan J. [1 ]
Thompson, Samuel [1 ]
Mavis, Cory [1 ]
Torka, Pallawi [1 ]
Hernandez-Ilizaliturri, Francisco [1 ]
机构：
[1] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2404
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2404
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic Leukemia
    Hohtari, Helena
    Kankainen, Matti
    Adnan-Awad, Shady
    Yadav, Bhagwan
    Potdar, Swapnil
    Ianevski, Aleksandr
    Dufva, Olli
    Heckman, Caroline
    Sexl, Veronika
    Kytola, Soili
    Mustjoki, Satu
    Porkka, Kimmo
    [J]. HEMASPHERE, 2022, 6 (03): : E701
  • [32] MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors
    Howard, Thomas P.
    Arnoff, Taylor E.
    Song, Melinda R.
    Giacomelli, Andrew O.
    Wang, Xiaofeng
    Hong, Andrew L.
    Dharia, Neekesh, V
    Wang, Su
    Vazquez, Francisca
    Minh-Tam Pham
    Morgan, Ann M.
    Wachter, Franziska
    Bird, Gregory H.
    Kugener, Guillaume
    Oberlick, Elaine M.
    Rees, Matthew G.
    Tiv, Hong L.
    Hwang, Justin H.
    Walsh, Katherine H.
    Cook, April
    Krill-Burger, John M.
    Tsherniak, Aviad
    Gokhale, Prafulla C.
    Park, Peter J.
    Stegmaier, Kimberly
    Walensky, Loren D.
    Hahn, William C.
    Roberts, Charles W. M.
    [J]. CANCER RESEARCH, 2019, 79 (09) : 2404 - 2414
  • [33] TARGETING HDM2 (HUMAN MDM2) IN SARCOMAS
    Maki, R. G.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 54 - 54
  • [34] Pharmacological targeting of Mdm2: Rationale and perspectives for radiosensitization
    Chargari, C.
    Leteur, C.
    Ferte, C.
    Deberne, M.
    Lahon, B.
    Rivera, C.
    Bourhis, J.
    Deutsch, E.
    [J]. CANCER RADIOTHERAPIE, 2011, 15 (04): : 316 - 322
  • [35] Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma
    Warner, Kristy A.
    Noer, Felipe
    Acasigua, Gerson A.
    Martins, Manoela D.
    Zhang, Zhaocheng
    McLean, Scott A.
    Spector, Matthew E.
    Chepeha, Douglas B.
    Helman, Joseph
    Wick, Michael J.
    Moskaluk, Christopher A.
    Castilho, Rogerio M.
    Pearson, Alexander T.
    Wang, Shaomeng
    Noer, Jacques E.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (14) : 3550 - 3559
  • [36] Mdm2: A regulator of cell growth and death
    Vargas, DA
    Takahashi, S
    Ronai, Z
    [J]. ADVANCES IN CANCER RESEARCH, VOL 89, 2003, 89 : 1 - 34
  • [37] Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours
    Bauer, Sebastian
    Muehlenberg, Thomas
    Leahy, Michael
    Hoiczyk, Mathias
    Gauler, Thomas
    Schuler, Martin
    Looijenga, Leendert
    [J]. EUROPEAN UROLOGY, 2010, 57 (04) : 679 - 687
  • [38] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk
    Roberto Salvi
    Manuela Argentini
    Christine Dureuil
    Isabelle Delumeau
    Joseph Abecassis
    Laurent Debussche
    Bohdan Wasylyk
    [J]. Oncogene, 1999, 18 : 1921 - 1934
  • [39] The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor
    Eskandari, Mohammad
    Shi, Yang
    Liu, John
    Albanese, Joseph
    Goel, Swati
    Verma, Amit
    Wang, Yanhua
    [J]. LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 167 - 175
  • [40] Expression of MDM2 oncoprotein predicts for poor survival in diffuse large B-cell lymphoma (DLBCL) with wild-type TP53 gene
    Young, K. H.
    Moller, M. B.
    Colleoni, G. W. B.
    Sánchez-Beato, M.
    Green, T. M.
    Thorborg, T.
    Piris, M. A.
    Twohig, M.
    Young, A. H.
    Oberley, T. D.
    Matter, J. S.
    Ferry, J. A.
    Chan, W. C.
    Weisenburger, D. D.
    Greiner, T. C.
    [J]. MODERN PATHOLOGY, 2008, 21 : 283A - 283A
12345